U.S. Health Care REITs Stock News

NasdaqCM:CXDO
NasdaqCM:CXDOIT

High Growth Tech Stocks to Watch in the US May 2026

The United States market has shown a robust performance, climbing 3.2% in the last week and up 31% over the past year, with earnings forecasted to grow by 16% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and scalability to capitalize on these favorable market conditions.
NasdaqGS:FFBC
NasdaqGS:FFBCBanks

Top Dividend Stocks To Consider In May 2026

The United States market has shown robust growth, climbing 3.2% in the past week and an impressive 31% over the last year, with earnings projected to grow by 16% annually. In such a dynamic environment, dividend stocks that offer both reliable income and potential for capital appreciation can be particularly appealing to investors seeking stability amidst market fluctuations.
NasdaqGS:FLEX
NasdaqGS:FLEXElectronic

US Stock Market Today S&P 500 Futures Edge Higher As Rate Relief Hopes Build

The Morning Bull - US Market Morning Update Thursday, May, 7 2026 E-mini S&P 500 futures are a touch higher this morning, as investors weigh easing tensions in the Middle East against fresh signs of a mixed global economy. Hopes for progress in US Iran talks have pushed oil prices lower and pulled the US 10 year Treasury yield down to around 4.35%, which can ease borrowing costs for households and companies. At the same time, US private employers added 109,000 jobs in April, the strongest...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

ASCENIV Pediatric Approval Tests ADMA Biologics Growth Story And Risks

FDA approves an expanded label for ASCENIV to include pediatric immunodeficiency patients aged two and older. The decision allows earlier intervention for immune compromised children and broadens ASCENIV’s eligible patient pool. The approval fulfills a key post marketing commitment for ADMA Biologics and may influence future commercial uptake. For ADMA Biologics (NasdaqGM:ADMA), this regulatory milestone arrives with the stock trading at $10.08 after a very large 5 year return and a 182.4%...